Who has invested in Poseida Therapeutics?

Novartis, Carlyle, RA Capital are named among the investors backing Poseida Therapeutics.

Poseida Therapeutics Funding: $313M Raised, Series B (2020)

Poseida Therapeutics funding overview

Poseida Therapeutics is based in San Diego. Poseida Therapeutics has raised $313M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B announced in June 2020. The round record for Poseida Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include Novartis, Carlyle, RA Capital. 3 distinct backers are named across the disclosed rounds.

Poseida Therapeutics at a glance

Total raised: $313M
Latest round: Series B
Latest round date: June 2020
Headquarters: San Diego
Notable investors: Novartis, Carlyle, RA Capital

Frequently asked about Poseida Therapeutics funding

How much has Poseida Therapeutics raised?: Poseida Therapeutics has raised $313M in total disclosed funding across the rounds on record.
Who has invested in Poseida Therapeutics?: Novartis, Carlyle, RA Capital are named among the investors backing Poseida Therapeutics.
What was the latest Poseida Therapeutics funding round?: The most recent disclosed round is a Series B, announced in June 2020.
Where is Poseida Therapeutics based?: Poseida Therapeutics is based in San Diego.
When did Poseida Therapeutics last raise?: The last disclosed Poseida Therapeutics round closed in June 2020 at Series B.

Every Poseida Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in San Diego at a similar stage.

Poseida Therapeutics Funding: $313M Raised, Series B (2020)

Poseida Therapeutics funding overview

Poseida Therapeutics at a glance

Frequently asked about Poseida Therapeutics funding

Companies related to Poseida Therapeutics (36)

Browse related funding lists (8)